138 related articles for article (PubMed ID: 34336694)
1. Down-Regulation of Toll-Like Receptor 5 (TLR5) Increased VEGFR Expression in Triple Negative Breast Cancer (TNBC) Based on Radionuclide Imaging.
Jiang W; Han Y; Liang T; Zhang C; Gao F; Hou G
Front Oncol; 2021; 11():708047. PubMed ID: 34336694
[TBL] [Abstract][Full Text] [Related]
2. TLR5 is a new reporter for triple-negative breast cancer indicated by radioimmunoimaging and fluorescent staining.
Shi D; Liu W; Zhao S; Zhang C; Liang T; Hou G
J Cell Mol Med; 2019 Dec; 23(12):8305-8313. PubMed ID: 31576678
[TBL] [Abstract][Full Text] [Related]
3. TLR5: A prognostic and monitoring indicator for triple-negative breast cancer.
Shi D; Zhao S; Jiang W; Zhang C; Liang T; Hou G
Cell Death Dis; 2019 Dec; 10(12):954. PubMed ID: 31852883
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive imaging of Toll-like receptor 5 expression using
Yang C; Yun Q; Sun H; Yang G; Liang T; Zhang C; Song J; Han J; Hou G
Oncol Lett; 2014 Jun; 7(6):1919-1924. PubMed ID: 24932259
[TBL] [Abstract][Full Text] [Related]
5. In vivo Toll-like receptor 5 (TLR5) imaging with radiolabeled anti-TLR5 monoclonal antibody in rapamycin-treated mouse allogeneic skin transplantation model.
Sun H; Zhan Y; Liang T; Zhang C; Song J; Han J; Hou G
Transpl Infect Dis; 2015 Feb; 17(1):80-8. PubMed ID: 25573439
[TBL] [Abstract][Full Text] [Related]
6. Theranostic role of
Yang Q; Chen Z; Qiu Y; Huang W; Wang T; Song L; Sun X; Li C; Xu X; Kang L
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1246-1260. PubMed ID: 38135849
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive imaging of allogeneic transplanted skin graft by 131I-anti-TLR5 mAb.
Sun H; Yang G; Liang T; Zhang C; Song J; Han J; Hou G
J Cell Mol Med; 2014 Dec; 18(12):2437-44. PubMed ID: 25283154
[TBL] [Abstract][Full Text] [Related]
8. Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.
Zhao Z; Li Y; Shukla R; Liu H; Jain A; Barve A; Cheng K
Theranostics; 2019; 9(15):4508-4524. PubMed ID: 31285776
[TBL] [Abstract][Full Text] [Related]
9. Study of diffusion-weighted magnetic resonance imaging in the evaluation of the response to AAV2-VEGF-Trap neoadjuvant treatment in a triple-negative breast cancer animal model.
Li J; Zhu P; Wang L; Yang L; Zou L; Gao F
Cancer Med; 2019 Apr; 8(4):1594-1603. PubMed ID: 30900382
[TBL] [Abstract][Full Text] [Related]
10. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
[TBL] [Abstract][Full Text] [Related]
11. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS
J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
[TBL] [Abstract][Full Text] [Related]
13. A new PET tracer specific for vascular endothelial growth factor receptor 2.
Wang H; Cai W; Chen K; Li ZB; Kashefi A; He L; Chen X
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2001-10. PubMed ID: 17694307
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.
Capp C; Wajner SM; Siqueira DR; Brasil BA; Meurer L; Maia AL
Thyroid; 2010 Aug; 20(8):863-71. PubMed ID: 20615131
[TBL] [Abstract][Full Text] [Related]
15. Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis.
Ortega-Cava CF; Ishihara S; Rumi MA; Aziz MM; Kazumori H; Yuki T; Mishima Y; Moriyama I; Kadota C; Oshima N; Amano Y; Kadowaki Y; Ishimura N; Kinoshita Y
Clin Vaccine Immunol; 2006 Jan; 13(1):132-8. PubMed ID: 16426010
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Local Injection of Bevacizumab against Triple-Negative Breast Cancer Xenograft Tumors.
Jiang X; Zhang QL; Liu TG; Zhao WP; Yang M; Wang LN; Sun WL; Pan L; Luo AP; Huang JC; Gu XH
Curr Pharm Des; 2019; 25(8):862-870. PubMed ID: 30848190
[TBL] [Abstract][Full Text] [Related]
17. A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth.
Assareh E; Mehrnejad F; Mansouri K; Esmaeili Rastaghi AR; Naderi-Manesh H; Asghari SM
Biochem J; 2019 Feb; 476(4):645-663. PubMed ID: 30700502
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti-vascular endothelial growth factor receptor-2 antibody.
Rakhmilevich AL; Hooper AT; Hicklin DJ; Sondel PM
Mol Cancer Ther; 2004 Aug; 3(8):969-76. PubMed ID: 15299079
[TBL] [Abstract][Full Text] [Related]
19. Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.
Terwisscha van Scheltinga AG; Berghuis P; Nienhuis HH; Timmer-Bosscha H; Pot L; Gaykema SB; Lub-de Hooge MN; Kosterink JG; de Vries EG; Schröder CP
Eur J Cancer; 2014 Sep; 50(14):2508-16. PubMed ID: 25027745
[TBL] [Abstract][Full Text] [Related]
20. Polydatin down-regulates the phosphorylation level of STAT3 and induces pyroptosis in triple-negative breast cancer mice with a high-fat diet.
Liu M; Li Y; Kong B; Zhang G; Zhang Q
Ann Transl Med; 2022 Feb; 10(4):173. PubMed ID: 35280371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
